|
CAS-Nr. | 168079-32-1 |
Bezeichnung: | |
Englisch Name: | LIXIVAPTAN |
Synonyma: | VPA 985;LIXIVAPTAN;N-[3-Chloro-4-(5H-pyrrolo[2,1-c][1,4]benzodiazepin-10(11H)-ylcarbonyl)phenyl]-5-fluoro-2-methylbenzamide;N-[3-Chloro-4-(5H-pyrrolo[2,1-c][1,4]benzodiazepine-10(11H)-ylcarbonyl)phenyl]-5-fluoro-2-methylbenzamide;BenzaMide,N-[3-chloro-4-(5H-pyrrolo[2,1-c][1,4]benzodiazepin-10(11H)-ylcarbonyl)phenyl]-5-fluoro-2-Methyl- |
CBNumber: | CB22446529 |
Summenformel: | C27H21ClFN3O2 |
Molgewicht: | 473.933 |
MOL-Datei: | 168079-32-1.mol |
|
|
|
|
LIXIVAPTAN physikalisch-chemischer Eigenschaften |
|
storage temp. : |
room temp |
|
|
LIXIVAPTAN Chemische Eigenschaften,Einsatz,Produktion Methoden |
Verwenden Drug used in the treatment and prevention of cardiovascular diseases. |
|
|
LIXIVAPTAN Upstream-Materialien And Downstream Produkte |
Upstream-Materialien
|
Downstream Produkte
|
LIXIVAPTAN Anbieter Lieferant Produzent Hersteller Vertrieb Händler. Global( 16)Lieferanten |
|
|
|
|
168079-32-1
LIXIVAPTAN
N-[3-Chloro-4-(5H-pyrrolo[2,1-c][1,4]benzodiazepin-10(11H)-ylcarbonyl)phenyl]-5-fluoro-2-methylbenzamide
C27H21ClFN3O2
VPA 985
Aromatics
Heterocycles
Intermediates & Fine Chemicals
Pharmaceuticals
BenzaMide,N-[3-chloro-4-(5H-pyrrolo[2,1-c][1,4]benzodiazepin-10(11H)-ylcarbonyl)phenyl]-5-fluoro-2-Methyl-
N-[3-Chloro-4-(5H-pyrrolo[2,1-c][1,4]benzodiazepine-10(11H)-ylcarbonyl)phenyl]-5-fluoro-2-methylbenzamide
|